Dr. Arthur Moss answers the question: 'Cardiac Resynchronization Device?' — -- Question: What is a cardiac resynchronization device, and is it the same as a pacemaker? Answer:Well, in a way it's ...

Receipt of a cardiac-resynchronization therapy-defibrillator (CRT-D) offers long term benefit for patients with heart failure, reduced ejection fraction, and a widened QRS complex, according to a ...

Contemporary cardiac resynchronization therapy (CRT) devices are equipped with reliable and extensive diagnostic and memory features yielding full disclosure of the frequency, duration, and overall ...

We tested the hypothesis that prophylactic cardiac-resynchronization therapy in the form of biventricular stimulation with a pacemaker with or without a defibrillator would reduce the risk of death ...

Background Studies of cardiac resynchronization therapy in addition to an implantable cardioverter defibrillator in patients with mild to moderate congestive heart failure had not been shown to reduce ...

Data Demonstrate Clinical and Economic Value of Underutilized Treatment for Heart Failure Patients at American Heart Association's Scientific Sessions 2014 MINNEAPOLIS and CHICAGO - Medtronic, Inc.

A meta-analysis by investigators from FDA of three major trials of cardiac resynchronization therapy (CRT) demonstrated that women have a reduced rate of heart failure (HF) and death with CRT at a ...

MINNEAPOLIS - Medtronic, Inc. today announced CE (Conformité Européenne) Mark receipt and the European launch of its newest cardiac resynchronization therapy-pacemaker, Viva® CRT-P. The Viva CRT-P is ...

Two new trials have ended up reporting conflicting results regarding the expansion of the indication for cardiac resynchronization therapy (CRT) for patients without a wide QRS interval. The positive ...

Heart failure is a fatal condition that can put a patient’s life at stake. Heart conditions are caused due to the ill-functioning of the heart due to various internal and lifestyle situations.

New York, USA, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The Global Cardiac Resynchronization Therapy Market is expected to Register an Immense Growth at a CAGR of 6.49% During the Forecast Period (2019–2027) ...